— Know what they know.
Not Investment Advice

TWST NASDAQ

Twist Bioscience Corporation
1W: +11.1% 1M: -6.9% 3M: +21.1% YTD: +81.7% 1Y: +90.4% 3Y: +355.8% 5Y: -36.5%
$60.57
+1.74 (+2.95%)
 
Weekly Expected Move ±8.2%
$41 $45 $49 $53 $57
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 50 · $3.8B mcap · 60M float · 2.10% daily turnover · Short 54% of daily vol

Cash Flow Trends

Operating Cash Flow
-$48M +25.7% ▲
Capital Expenditures
$28M -451.7% ▼
5Y CAGR: +23.2%
Free Cash Flow
-$76M -9.3% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$16K +99.6% ▲
Net Change in Cash
-$43M +28.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$152M-$218M-$205M-$209M-$78M
Depreciation & Amort.$10M$17M$29M$31M$25M
Stock-Based Comp.$37M$80M$30M$51M$64M
Change in Working Capital-$9M-$5M-$1M$15M-$13M
Other Non-Cash Items$2M$3M$4M$47M-$47M
Operating Cash Flow-$112M-$124M-$142M-$64M-$48M
— Investing Activities —
Capital Expenditures-$27M-$102M-$28M-$5M-$28M
Acquisitions (Net)-$483K-$8M$6M$0$2M
Investment Purchases-$59M-$218M-$76M-$52M-$49M
Investment Sales$242M$100M$155M$54M$50M
Other Investing$0-$6M-$6M$0$0
Investing Cash Flow$156M-$233M$51M-$3M-$25M
— Financing Activities —
Net Debt Issuance-$3M-$2M$0$0$0
Stock Repurchased-$11M-$8M-$4M-$4M-$16K
Dividends Paid$0$0$0$0$0
Other Financing$20M$10M$5M$11M$15M
Financing Cash Flow$329M$271M$911K$7M$29M
Net Change in Cash$373M-$87M-$91M-$60M-$43M
Cash End of Period$467M$380M$289M$229M$183M
Free Cash Flow-$139M-$226M-$170M-$69M-$76M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms